CPIG
CORT icon

Chicago Partners Investment Group’s Corcept Therapeutics CORT Stock Holding History

Chicago Partners Investment Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$752K Buy
+7,777
New +$470K 0.02% 786
2018
Q4 		– Sell
-1,180
Closed -$14K – 442
2018
Q3 		$14K Buy
1,180
+360
+44% +$5.03K ﹤0.01% 745
2018
Q2 		$13K Buy
+820
New +$14.3K ﹤0.01% 746

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Chicago Partners Investment Group's CORT Position: Q2 2026 in Review

Chicago Partners Investment Group opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 7,777 shares worth $752K. The stake represents 0.02% of the portfolio and ranks #786 among its holdings. This is a return to the name: Chicago Partners Investment Group previously reported a position in CORT as recently as Q3 2018.

Chicago Partners Investment Group first reported a position in CORT in Q2 2018 and has held it in 3 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Chicago Partners Investment Group held 7,777 shares of Corcept Therapeutics worth $752K as of Q2 2026.
  • Corcept Therapeutics was a new Chicago Partners Investment Group position in Q2 2026.
  • Corcept Therapeutics made up 0.02% of Chicago Partners Investment Group's portfolio in Q2 2026, its #786 holding.
  • Chicago Partners Investment Group first reported a position in Corcept Therapeutics in Q2 2018 and has held it in 3 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.